Lung Biology Center, University of California San Francisco, San Francisco, CA, United States.
Lung Biology Center, University of California San Francisco, San Francisco, CA, United States.
Adv Immunol. 2019;142:1-34. doi: 10.1016/bs.ai.2019.05.001. Epub 2019 Jul 1.
Asthma is a genetically and phenotypically complex disease that has a major impact on global health. Signs and symptoms of asthma are caused by the obstruction of airflow through the airways. The epithelium that lines the airways plays a major role in maintaining airway patency and in host defense. The epithelium initiates responses to inhaled or aspirated substances, including allergens, viruses, and bacteria, and epithelial-derived cytokines are important in the recruitment and activation of immune cells in the airway. Changes in the structure and function of the airway epithelium are a prominent feature of asthma. Approximately half of individuals with asthma have evidence of active type 2 immune responses in the airway. In these individuals, epithelial cytokines promote type 2 responses, and responses to type 2 cytokines result in increased epithelial mucus production and other effects that cause airway obstruction. Recent work also implicates other epithelial responses, including interleukin-17, interferon and ER stress responses, that may contribute to asthma pathogenesis and provide new targets for therapy.
哮喘是一种具有遗传和表型复杂性的疾病,对全球健康有重大影响。哮喘的体征和症状是由气道气流阻塞引起的。气道衬里的上皮在维持气道通畅和宿主防御方面起着重要作用。上皮细胞对吸入或吸入的物质(包括过敏原、病毒和细菌)产生反应,上皮衍生的细胞因子在气道中免疫细胞的募集和激活中很重要。气道上皮结构和功能的改变是哮喘的一个显著特征。大约一半的哮喘患者的气道中有活性 2 型免疫反应的证据。在这些患者中,上皮细胞因子促进 2 型反应,对 2 型细胞因子的反应导致上皮黏液产生增加和其他导致气道阻塞的效应。最近的研究还表明其他上皮反应,包括白细胞介素-17、干扰素和 ER 应激反应,可能与哮喘发病机制有关,并为治疗提供新的靶点。